Detecting cancer early improves treatment effectiveness and increases positive outcomes. With millions of new cases annually, many cancers are found at advanced stages, requiring intensive treatments with higher risks and costs. Early cancer screening is crucial for better health outcomes.
Trucheck™ is an advanced cancer screening test available at Bodyvie, designed to detect circulating tumour cells (CTCs) and their clusters in the blood. Malignant tumours release these cells, which are absent in benign or inflammatory tissues. Trucheck™ can identify around 70 types of solid tumours, accounting for 81% of all cancer cases and 84% of cancer-related deaths in Europe.
Clinical studies have shown that Trucheck™ has an 88% sensitivity in detecting cancers at various stages and types, with a 96% accuracy in determining the tissue or organ of origin in positive cases. Trucheck™ effectively detects even early-stage cancers, making it a highly reliable option for early cancer screening.
Which Cancers Does the Test Check For?
Trucheck™ can detect approximately 70 different types of solid tumours, including but not limited to:
- Breast cancer
- Lung cancer
- Colorectal cancer
- Pancreatic cancer
- Prostate cancer
- Ovarian cancer
- Gastric cancer
- Liver cancer
Why Consider Cancer Screening?
Cancer incidence is rising due to factors like lifestyle changes, diet, smoking, stress, and an ageing population. In the UK, 1 in 2 people born after 1960 will be diagnosed with cancer in their lifetime. Early cancer screening significantly improves survival rates and reduces treatment costs.
Globally, cancer contributes to millions of new cases and deaths each year:
- 4.1 million new cases and 1.8 million deaths in Europe
- 2.1 million new cases and 550,000 deaths in the US
- 1.2 million new cases and 760,000 deaths in India
Early cancer screening is crucial for saving lives. Trucheck™ offers a non-invasive blood test to detect multiple cancers in asymptomatic individuals, many of which are not covered by routine screenings.
Several Key Benefits
- Detects multiple cancer types with a single blood draw
- Provides detailed tissue or organ of origin information
- Guides further diagnostic steps, reducing unnecessary procedures
- High sensitivity and specificity for early detection
How Does The Test Process Work?
Consultation
Your journey begins with a consultation at Bodyvie, where our specialists will discuss your medical history, risk factors, and the benefits of the Trucheck™ test.
Blood Draw
A small blood sample is taken from your arm, similar to a routine blood test. This sample contains circulating tumour cells (CTCs) if present.
CTC Enrichment
The sample is sent to the laboratory, where it undergoes Trucheck™’s unique epigenetically activating medium (EAM) process. This method isolates malignant cells by killing non-malignant cells through their functional apoptosis machinery.
Analysis
The enriched sample is then analysed for CTCs and clusters. Trucheck™ intelli technology distinguishes ~70 types of solid tumours and provides detailed information about the tissue or organ of origin.
Results
Within a few weeks, you will receive a comprehensive report detailing the findings. Our specialists will review the results with you, providing guidance on any necessary follow-up actions or treatments.
Method
Trucheck™ employs a unique approach to CTC enrichment. Traditional methods rely on immuno-affinity capture or size/charge-based separation, which have limitations in sensitivity and specificity.
It uses an epigenetically activating medium (EAM) to selectively enrich CTCs by exploiting their resistance to apoptosis. This method effectively isolates malignant cells while eliminating non-malignant ones, ensuring high accuracy in early cancer screening.
Trucheck™ is particularly recommended for:
- Asymptomatic individuals with a family history of cancer
- Those who wish to include early cancer screening in their annual check-up
- Individuals at high risk of developing cancer
Trucheck™ is a revolutionary cancer screening test that leverages the detection of CTCs and C-ETACs from a blood sample. These cells are prevalent in patients with solid organ cancers but absent in healthy individuals, making Trucheck™ a powerful tool for early cancer detection.
Ensure your health and peace of mind with early cancer screening at Bodyvie.
